Gerresheimer sets up new production facility for insulin pen systems in Brazil

Düsseldorf (ots) -

* Expansion of cooperation with diabetes leader Novo Nordisk
* Important step in the worldwide development of medical plastic
systems

The Gerresheimer Group has set up a new facility for medical
plastic systems in Indaiatuba (Brazil). The plant is to commence
operations early in 2010. On the basis of a long-term cooperation
agreement with Novo Nordisk, components will be produced with
state-of-the-art technology for insulin pen systems for diabetics.

Insulin pens are drug-delivery devices in ball-point pen format
which allow diabetes patients to inject themselves with the regularly
required insulin dose safely and almost painlessly. Novo Nordisk as
the world's leading insulin producer has contracted Gerresheimer to
manufacture components for its insulin pens. Novo Nordisk has a large
insulin plant in Brazil which will in future be supplied locally by
the new technology center of the Gerresheimer Group. For Gerresheimer
this is already the fourth production plant in South America in
addition to two existing plants for standardized pharma plastic
packaging in Brazil and one in Argentina.

Apart from the new production facility in Brazil, Gerresheimer
already has two other production facilities for pen systems in
Europe.

"Cooperation with Novo Nordisk in Brazil is of substantial
strategic importance for us. We support the customer in developing
new markets and at the same time expand our technological base in
South America," says Gerresheimer CEO Dr. Axel Herberg.

About Gerresheimer

Gerresheimer employs around 10,000 people in 40 locations in
Europe, America and Asia. In the financial year 2008, worldwide sales
totaled EUR 1.06bn. The product portfolio ranges from pharmaceutical
vials made of glass and plastic through to complex drug-delivery
systems for the pharma & healthcare industry. These include sterile
syringes, inhalers and other system-based approaches for safe dosage
and application of medications. The Group enjoys a leading position
in markets which are characterized by high technical and regulatory
barriers.

Originaltext: Gerresheimer AG
digital press kits: http://www.presseportal.de/pm/9072
press kits via RSS: http://www.presseportal.de/rss/pm_9072.rss2
ISIN: DE000A0LD6E6

Contact:
Contact Press
Burkhard Lingenberg
Director Corporate Communication & Marketing
Phone +49 211 6181-250
Fax +49 211 6181-241
e-mail b.lingenberg@gerresheimer.com

Contact Investor Relations
Anke Linnartz
Director Corporate Investor Relations
Phone +49 211 6181-314
Fax +49 211 6181-121
e-mail a.linnartz@gerresheimer.com